Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism EphA2 antagonists(Ephrin type-A receptor 2 antagonists), Raf kinase inhibitors(RAF serine/threonine protein kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | US | 26 Oct 2022 | |
Solid tumor | Preclinical | CN | 26 Oct 2022 |